Skip to main content
. Author manuscript; available in PMC: 2014 Nov 14.
Published in final edited form as: Immunity. 2013 Oct 24;39(5):10.1016/j.immuni.2013.10.006. doi: 10.1016/j.immuni.2013.10.006

Figure 5. Immunization with bvPLA2 protects from subsequent challenge with a near-lethal dose of bvPLA2 in a B cell- and FcεR-dependent manner.

Figure 5

(A) Rectal temperature measurements of naïve or immunized C57Bl/6 mice challenged with a near-lethal dose of bvPLA2. Mice were immunized intraperitoneally for 6 consecutive weeks with 50μg bvPLA2 before challenge. (B) Rectal temperatures of naïve or immunized C57Bl/6 and B cell-deficient muMT mice treated as in (A). (C) Rectal temperatures of naïve or immunized C57Bl/6 and Fcer1a−/− mice treated as in (A). *P<0.05; **<0.005; ***P<0.001. All error bars show s.e.m. Data are representative of at least three experiments. See also Figure S4.